Literature DB >> 26173672

Endothelin type A receptor inhibition normalises intrarenal hypoxia in rats used as a model of type 1 diabetes by improving oxygen delivery.

Stephanie Franzén1,2, Fredrik Palm3,4,5.   

Abstract

AIMS/HYPOTHESIS: Intrarenal tissue hypoxia, secondary to increased oxygen consumption, has been suggested as a unifying mechanism for the development of diabetic nephropathy. Increased endothelin-1 signalling via the endothelin type A receptor (ETA-R) has been shown to contribute to the development of chronic kidney disease, but its role in kidney oxygen homeostasis is presently unknown.
METHODS: The effects of acute ETA-R inhibition (8 nmol/l BQ-123 for 30-40 min directly into the left renal artery) on kidney function and oxygen metabolism were investigated in normoglycaemic control and insulinopenic male Sprague Dawley rats (55 mg/kg streptozotocin intravenously 2 weeks before the main experiment) used as a model of type 1 diabetes.
RESULTS: Local inhibition of ETA-R in the left kidney did not affect BP in either the control or the diabetic rats. As previously reported, diabetic rats displayed increased kidney oxygen consumption resulting in tissue hypoxia in both the kidney cortex and medulla. The inhibition of ETA-Rs restored normal kidney tissue oxygen availability in the diabetic kidney by increasing renal blood flow, but did not affect oxygen consumption. Furthermore, ETA-R inhibition reduced the diabetes-induced glomerular hyperfiltration and increased the urinary sodium excretion. Kidney function in normoglycaemic control rats was largely unaffected by BQ-123 treatment, although it also increased renal blood flow and urinary sodium excretion in these animals. CONCLUSIONS/
INTERPRETATION: Acutely reduced intrarenal ETA-R signalling results in significantly improved oxygen availability in the diabetic kidney secondary to elevated renal perfusion. Thus, the beneficial effects of ETA-R inhibition on kidney function in diabetes may be due to improved intrarenal oxygen homeostasis.

Entities:  

Keywords:  BQ-123; Diabetic nephropathy; Endothelin type A receptor; Hypoxia; Kidney function; Rats

Mesh:

Substances:

Year:  2015        PMID: 26173672     DOI: 10.1007/s00125-015-3690-9

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  44 in total

1.  Elevated plasma endothelin in patients with diabetes mellitus.

Authors:  K Takahashi; M A Ghatei; H C Lam; D J O'Halloran; S R Bloom
Journal:  Diabetologia       Date:  1990-05       Impact factor: 10.122

Review 2.  2013 Dahl Lecture: American Heart Association council for high blood pressure research clarifying the physiology of endothelin.

Authors:  David M Pollock
Journal:  Hypertension       Date:  2014-03-10       Impact factor: 10.190

3.  Adenosine A2 a receptor stimulation prevents proteinuria in diabetic rats by promoting an anti-inflammatory phenotype without affecting oxidative stress.

Authors:  P Persson; M Friederich-Persson; A Fasching; P Hansell; R Inagi; F Palm
Journal:  Acta Physiol (Oxf)       Date:  2015-05-06       Impact factor: 6.311

4.  Basal renal O2 consumption and the efficiency of O2 utilization for Na+ reabsorption.

Authors:  Roger G Evans; Gerard K Harrop; Jennifer P Ngo; Connie P C Ow; Paul M O'Connor
Journal:  Am J Physiol Renal Physiol       Date:  2014-01-15

5.  Endothelin's biphasic effect on fluid absorption in the proximal straight tubule and its inhibitory cascade.

Authors:  N H Garcia; J L Garvin
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

6.  Increased renal metabolism in diabetes. Mechanism and functional implications.

Authors:  A Körner; A C Eklöf; G Celsi; A Aperia
Journal:  Diabetes       Date:  1994-05       Impact factor: 9.461

7.  Angiotensin II contributes to glomerular hyperfiltration in diabetic rats independently of adenosine type I receptors.

Authors:  Daniela Patinha; Angelica Fasching; Dora Pinho; António Albino-Teixeira; Manuela Morato; Fredrik Palm
Journal:  Am J Physiol Renal Physiol       Date:  2013-01-02

Review 8.  Endothelin and NOS1/nitric oxide signaling and regulation of sodium homeostasis.

Authors:  Jennifer S Pollock; David M Pollock
Journal:  Curr Opin Nephrol Hypertens       Date:  2008-01       Impact factor: 2.894

9.  Distribution of endothelin receptor subtypes in the rat kidney. Renal and haemodynamic effects of the mixed (A/B) endothelin receptor antagonist bosentan.

Authors:  B Hocher; P Rohmeiss; F Diekmann; R Zart; V Vogt; S Schiller; C Bauer; K Koppenhagen; A Distler; N Gretz
Journal:  Eur J Clin Chem Clin Biochem       Date:  1995-08

Review 10.  Determinants of kidney oxygen consumption and their relationship to tissue oxygen tension in diabetes and hypertension.

Authors:  Peter Hansell; William J Welch; Roland C Blantz; Fredrik Palm
Journal:  Clin Exp Pharmacol Physiol       Date:  2013-02       Impact factor: 2.557

View more
  1 in total

1.  Predicted consequences of diabetes and SGLT inhibition on transport and oxygen consumption along a rat nephron.

Authors:  Anita T Layton; Volker Vallon; Aurélie Edwards
Journal:  Am J Physiol Renal Physiol       Date:  2016-01-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.